Lectin-like oxidized low-density lipoprotein receptor-1: Protein, ligands, expression and pathophysiological significance

Chinese Medical Journal

Volumn 120, Issue 5, 2007, Pages 421-426

  Chen, Xiu Ping ^a   Du, Guan Hua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Atherosclerosis; Class E; Endothelial cells; Oxidized low density lipoprotein; Scavenger receptors

Indexed keywords

ATORVASTATIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SERINE PROTEINASE INHIBITOR; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ADHESION; CRYSTAL STRUCTURE; DISEASE MARKER; DRUG DOSE INCREASE; DRUG MECHANISM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; LIGAND BINDING; MEDLINE; MOLECULAR WEIGHT; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33947630915     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200703010-00015     Document Type: Review

References (35)

1. Itabe H. Oxidized tow-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 2003; 26:1-9.
2. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386: 73-77.
3. Mingyi C, Tomoh M, Tatsuya S. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002; 95:89-100.
4. Chen M, Narumiya S, Masaki T, Sawamura T. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J 2001; 355:289-296.
5. Shi X, Niimi S, Ohtani T, Machida S. Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci 2001; 114:1273-1282.
6. Chen M, Inoue K, Narumiya S, Masaki T, Sawamura T. Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein. FEBS Lett 2001; 499:215-219.
7. Park H, Adsit FG, Boyington JC. The crystal structure of the human oxidized low density lipoprotein receptor Lox-1. J Biol Chem 2005; 280:13593-13599.
8. Kataoka H, Kume N, Miyamoto S, Minami M, Murase T, Sawamura T, et al. Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding. J Biol Chem 2000; 275:6573-6579.
9. Kume N, Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol 2001; 12:419-423.
10. Hayashida Y, Kume N, Murase T, Minami M, Nakagawa D, Inada T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 2005; 112:812-818.
11. Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, Sakakibara Y, et al. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol 2004; 23:111-117.
12. Moriwaki H, Kume N, Sawamura T, Aoyama T, Hoshikawa H, Ochi H, et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 1998; 18: 1541-1547.
13. Kakutani M, Ueda M, Naruko T, Masaki T, Sawamura T. Accumulation of LOX-1 ligand in plasma and atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits: identification by a novel enzyme immunoassay. Biochem Biophys Res Commun 2001; 282:180-185.
14. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 2002; 511: 170-174.
15. Yamanaka S, Zhang XY, Miura Y, Kim S, Iwao H. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics 1998; 54:191-199.
16. Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, Sawamura T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-α. FEBS Lett 1998; 440:29-32.
17. Li D, Singh RM, Liu L, Chen H, Singh BM, Kazzaz N, et al. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc Res 2003; 57:238-243.
18. Li L, Sawamura T, Renier G. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 2003; 52:1843-1850.
19. Aoyama T, Fujiwara H, Masaki T, Sawamura T. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol 1999; 31:2101-2114.
20. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 2001; 947:199-205.
21. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectin like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999; 99: 3110-3117.
22. Kakutani M, Masaki T, Sawamura T. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci USA 2000; 97:360-364.
23. Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, et al. Oxidized LDL modulates Bax/Bcl-2 through the lectin-like Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21:955-960.
24. Mehta JL, Li DY, Chen HJ, Joseph J, Romeo F. Inhibition of LOX-1 by statins may relate to upregulation of eNOS. Biochem Biophys Res Commun 2001; 289: 857-861.
25. Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability-analysis in hypercholesterolemic rabbits. Atherosclerosis 2007; 18: [Epub ahead of print].
26. Nakagawa T, Akagi M, Hoshikawa H, Chen M, Yasuda T, Mukai S, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates leukocyte infiltration and articular cartilage destruction in rat zymosan-induced arthritis. Arthritis Rheum 2002; 46: 2486-2494.
27. Takefumi N, Tadashi Y, Hajime H, Shimizu M, Kakinuma T, Chen M, et al. LOX-1 expressed in cultured rat chondrocytes mediated oxidized LDL-induced cell death-prossible role of dephosphorylation of Akt. Biochem Biophys Res Commun 2002; 299: 91-97.
28. Akagi M, Kanata S, Mori S, Itabe H, Sawamura T, Hamanishi C. Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. Osteoarthritis Cartilage 2006; 28: [Epub ahead of print].
29. Kanata S, Akagi M, Nishimura S, Hayakawa S, Yoshida K, Sawamura T, et al. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem Biophys Res Commun 2006; 348: 1003-1010.
30. Li D, Williams V, Liu L, Chen H, Chen H, Sawamura T, et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1048-1055.
31. Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303: 247-250.
32. Puccetti L, Pasqui AL, Bruni F, Pastorelli M, Ciani F, Palazzuoli A, et al. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment. Int J Cardict 2006; 12: [Epub ahead of print].
33. Cominacini L, Rigoni A, Fratta. PA, Garbin U, Davoli A, Campagnola M, et al. The binding of oxidized low-density lipoprotein (ox-LDL) to ox-LDL receptor-1 in endothelial cells reduces the intracellular concentration of nitric oxide through an increased production of superoxide. J Biol Chem 2001; 276:13750-13755.
34. Nishimura S, Akagi M, Yoshida K, Hayakawa S, Sawamura T, Munakata H, et al. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthritis Cartilage 2004; 12:568-576.
35. Thomas T, Jürgen B. Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury therapy through LOX-1 receptor antagonism? Circ Res 2004; 94:1-13.